Global Induced Pluripotent Stem Cells market will reach 160.9 million US$ by the end of 2025
Publisher: QYResearch
Published Date: 2019/9/12
The global induced pluripotent stem cells market is expected to grow with its increasing usage as a regenerative medicine for damaged tissues and diseased organs. This is attributed towards an interesting property of pluripotent stem cells to form various types of adult cells such as neurons, liver, heart, and pancreatic cells. They also can make any cell or tissue combat diseases such as spinal cord injury, diabetes, heart disease, and leukaemia. These cells can be modified to match patient’s genetic makeup. Governments and private sectors are investing heavily in the development of pluripotent stem cells as they enable initial human growth. Its ability to produce customized cells, rejection-proof cells, and tissues for efficacious transplantation is expected to offer lucrative opportunities to the global market for induced pluripotent stem cells.
Increasing interest among scientists to understand and develop stem cells for various ailments is expected to contribute towards the growth of stem cells. Its various roles in clinical applications, research and awareness among people about the benefits of stem cells will boost the market growth during the forecast period.
However, the treatment and reprogramming of cells is a lengthy and costly process. Also the market has certain ethical risks associated with it. Other factors like low efficiency, proliferation rates, potential tumour risk, and incomplete programming can hamper the growth of the global induced pluripotent stem cells market.
In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.
Click to view the full report:
https://www.qyresearch.com/index/detail/1243625/global-induced-pluripotent-stem-cells-market
This article was first released by QYResearch, if reproduced, please indicate the source.
Telephone number:020-86655165
Contact:press@qyresearch.com
When contacting, please refer to QYR company's Mia introduction.
Published Date: 2019/9/12
The global induced pluripotent stem cells market is expected to grow with its increasing usage as a regenerative medicine for damaged tissues and diseased organs. This is attributed towards an interesting property of pluripotent stem cells to form various types of adult cells such as neurons, liver, heart, and pancreatic cells. They also can make any cell or tissue combat diseases such as spinal cord injury, diabetes, heart disease, and leukaemia. These cells can be modified to match patient’s genetic makeup. Governments and private sectors are investing heavily in the development of pluripotent stem cells as they enable initial human growth. Its ability to produce customized cells, rejection-proof cells, and tissues for efficacious transplantation is expected to offer lucrative opportunities to the global market for induced pluripotent stem cells.
Increasing interest among scientists to understand and develop stem cells for various ailments is expected to contribute towards the growth of stem cells. Its various roles in clinical applications, research and awareness among people about the benefits of stem cells will boost the market growth during the forecast period.
However, the treatment and reprogramming of cells is a lengthy and costly process. Also the market has certain ethical risks associated with it. Other factors like low efficiency, proliferation rates, potential tumour risk, and incomplete programming can hamper the growth of the global induced pluripotent stem cells market.
In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.
Click to view the full report:
https://www.qyresearch.com/index/detail/1243625/global-induced-pluripotent-stem-cells-market
This article was first released by QYResearch, if reproduced, please indicate the source.
Telephone number:020-86655165
Contact:press@qyresearch.com
When contacting, please refer to QYR company's Mia introduction.



评论
发表评论